Trial Profile
Pain, anxiety and depression in neuropathic and non-neuropathic pain: Effect of monoamine modulation.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2012
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Fibromyalgia; Neuropathic pain; Pain
- Focus Therapeutic Use
- 07 Nov 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 09 Jul 2011 New trial record